Tim Schofield
co-Chair ; IABS
See the Biosketch
Kristi Griffiths
co-Chair ; Eli Lilly & Company
See the Biosketch
Rick Burdick
Burdick Consulting
See the Biosketch
Katherine Giacoletti
Synolostats
See the Biosketch
Theodoro Koulis
Genentech
See the Biosketch
Ruojia Li
Bristol-Myers Squibb
See the Biosketch
Tsai-lien Lin
U.S. FDA
Jia Liu
Pfizer
See the Biosketch
Guillermo Miro-Quesada
AstraZeneca
Julia O'Neill
DirexaConsultin
See the Biosketch
Laura Pack
Seattle Genetics
See the Biosketch
Jose Ramirez
Amgen
Christian Seifert
Boehringer-Ingelheim
See the Biosketch
Meiyu Shen
U.S. FDA
See the Biosketch
Jyh-Ming Shoung
Janssen
See the Biosketch

Confirmed speakers

Stan Altan
Johnson & Johnson
See the Biosketch See the Abstract
Maneesha Altekar
AstraZeneca
See the Biosketch See the Abstract
George Atkins
GlaxoSmithKline Pharmaceuticals
See the Biosketch
Timo Bailer
Boehringer Ingelheim
See the Biosketch See the Abstract
Rick Burdick
Burdick Consulting
See the Biosketch See the Abstract
Seth Clark
Merck & Co., Inc.
See the Biosketch
Kedar Dave
Bristol-Myers Squibb
See the Biosketch
David Enck
Janssen Pharmaceuticals
See the Biosketch See the Abstract
Phyllis Ferrell
Eli Lilly & Company
See the Biosketch
Amy Huang
Amgen
See the Abstract
Karthik IYER
FDA/CDER/OPQ/OQS/DQII
Theodoro Koulis
Genentech
See the Biosketch
Jia Liu
Pfizer
See the Biosketch
Melissa Matzke
Merck & Co., Inc.
See the Biosketch See the Abstract
Julia O'Neill
Direxa Consulting
See the Biosketch
Lori Pfahler
Merck & Co., Inc.
See the Biosketch
José Ramirez
Amgen
See the Biosketch See the Abstract
Tim Schofield
CMC Sciences, LLC
See the Biosketch
Gary Sullivan
Espirer Consulting
See the Biosketch See the Abstract

Access to meeting’s slides is given to meeting’s participants for a period of 4 weeks after the meeting.
A unique Login and password are sent by email to participants right after the meeting.
Afterwards the slides are only accessible to IABS member, using their Member Login and Password.


Click here to download the Meeting Slides

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific Alliance, governed by Articles 60-79 of the Swiss Civil code and by its Constitution. Its office is located in Geneva (Switzerland). IABS has members in over 50 countries.

Officers

Mission

IABS is devoted to the scientific and medical advancement of biologicals, by facilitating communication among those who develop, produce and regulate biological products for human and animal health.

Publications

Reports and proceedings of IABS conferences and workshops appear in its journal Biologicals, published by Elsevier and /or in the series Developments in Biologicals published by Karger.

Benefits of IABS Membership

As an Individual Member of IABS, you will:

  • Join a community of recognized experts
  • Receive a reduced fee for an electronic subscription to our journal Biologicals
  • Receive a reduced registration fee for IABS conferences and symposia
  • Have an opportunity to share thoughts, ideas and suggestions on IABS meetings, activities and goals via the dedicated member section on our website
  • Have the opportunity to vote in the election of IABS Board members

For more information on how to become a member of IABS, please visit: www.iabs.org